Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Working Capital Changes (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Other Working Capital Changes for 16 consecutive years, with $178.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 105.34% year-over-year to $178.0, compared with a TTM value of -$36880.0 through Sep 2025, down 110.02%, and an annual FY2024 reading of -$27565.0, down 209.87% over the prior year.
  • Other Working Capital Changes was $178.0 for Q3 2025 at China Pharma Holdings, down from $41246.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $365501.0 in Q4 2023 and bottomed at -$385348.0 in Q3 2023.
  • Average Other Working Capital Changes over 5 years is -$26566.5, with a median of -$9868.0 recorded in 2021.
  • Peak annual rise in Other Working Capital Changes hit 3066.01% in 2023, while the deepest fall reached 21945.12% in 2023.
  • Year by year, Other Working Capital Changes stood at -$215627.0 in 2021, then skyrocketed by 94.29% to -$12323.0 in 2022, then soared by 3066.01% to $365501.0 in 2023, then tumbled by 108.29% to -$30285.0 in 2024, then soared by 100.59% to $178.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for CPHI at $178.0 in Q3 2025, $41246.0 in Q2 2025, and -$48019.0 in Q1 2025.